Cardiovascular Disease Doctors in Shrewsbury, NJ Accepting Medicare

3 Cardiovascular Disease doctors found. Showing 1 - 3

Dr. Dale E Edlin, M.D. Internal Medicine - Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 179 Avenue At The Cmn, Suite 101, Shrewsbury, NJ 07702 Phone: 732-542-7600    Fax: 732-542-7655

Dr. David Brandon Zagha, M.D. Internal Medicine - Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 1026 Broad St Unit 18, Shrewsbury, NJ 07702 Phone: 732-542-0002    Fax: 732-542-2992

Charles Luther Miller, MD Internal Medicine - Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 30 Shrewsbury Plaza, Shrewsbury, NJ 07702 Phone: 732-542-2124    Fax: 732-460-0496

News Archive

AF Stat launch "AFib Educator" smartphone app and desktop widget

AF Stat- - a collaboration of healthcare leaders and organizations working to improve the health and well-being of people affected by atrial fibrillation (AFib) - today unveiled the "AFib Educator," a smartphone app and desktop widget to help healthcare practitioners better explain the risks and consequences of the disease to their patients.

ProMedica Toledo Hospital now has new tool to help evaluate breast tissue density on mammogram

Radiologists at ProMedica Toledo Hospital Breast Care Center have a new tool to help evaluate breast tissue density on a mammogram. It's called VolparaDensity™, a breast imaging software tool that uses complex physics and software to measure the amount of tissue within a patient's breast.

R&D of HIV treatments at crossroads

IP Overview HIV Therapy 2009" ( www.frinnov.fr/en/ip-overview/sciences-de-la-vie/hiv-therapy-2.html ) establishes a panorama of the patents claiming "HIV and AIDS treatments" and analyses the key and emerging thematic and the strategic positions of the actors involved in this sector. In order to fully analyze this field, the information coming from 6800 published patents and patent applications was aggregated.

New DNA-based Zika vaccine demonstrates safety and ability to elicit immune response

A new generation DNA-based Zika vaccine is the first to demonstrate both safety and the ability to elicit an immune response against Zika in humans, according to new research from the Perelman School of Medicine at the University of Pennsylvania, conducted in partnership with The Wistar Institute, Inovio Pharmaceuticals, and GeneOne Life Science, Inc.

FDA approves Novartis' Afinitor tablets for pancreatic NET treatment

Novartis Pharmaceuticals Corporation announced today that the US Food and Drug Administration approved Afinitor tablets for the treatment of progressive neuroendocrine tumors of pancreatic origin in patients with unresectable, locally advanced or metastatic disease.

Read more Medical News

› Verified 2 days ago